SCHEMBL905403

SCHEMBL905403

O=C(O)CCCCCCCCCCCCCC(=O)ON1C(=O)CCC1=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.43
LMNA P02545 2/20 0.43
NFKB1 P19838 1/20 0.43
PMP22 Q01453 1/20 0.43
PTGS1 P23219 4/20 0.40
PTGS2 P35354 4/20 0.40
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
GAA P10253 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.38
F13A1 P00488 3/20 0.38
GPR84 Q9NQS5 3/20 0.38
FFAR1 O14842 1/20 0.38
FFAR4 Q5NUL3 1/20 0.38
ALDH1A1 P00352 2/20 0.37
PPARG P37231 3/20 0.36
PPARD Q03181 3/20 0.36
PPARA Q07869 3/20 0.36
HDAC11 Q96DB2 2/20 0.36
TDP1 Q9NUW8 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL336568 1.00 TSHR (0.43) TSHRLMNANFKB1PMP22PTGS1
SCHEMBL337031 1.00 TSHR (0.43) TSHRLMNANFKB1PMP22PTGS1
SCHEMBL336648 1.00 TSHR (0.43) TSHRLMNANFKB1PMP22PTGS1
SCHEMBL1230060 1.00 TSHR (0.43) TSHRLMNANFKB1PMP22PTGS1
SCHEMBL25406852 1.00 TSHR (0.43) TSHRLMNANFKB1PMP22PTGS1
SCHEMBL25408775 1.00 TSHR (0.43) TSHRLMNANFKB1PMP22PTGS1
SCHEMBL25408793 1.00 TSHR (0.43) TSHRLMNANFKB1PMP22PTGS1
SCHEMBL25408300 1.00 TSHR (0.43) TSHRLMNANFKB1PMP22PTGS1
SCHEMBL25407766 1.00 TSHR (0.43) TSHRLMNANFKB1PMP22PTGS1
SCHEMBL337556 1.00 TSHR (0.43) TSHRLMNANFKB1PMP22PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2264065-B1 NOVEL INSULIN DERIVATIVES NOVO NORDISK AS (DK) 2017-03-08 EP disclosed
US-20140349925-A1 NOVEL INSULIN DERIVATIVES NOVO NORDISK AS (DK) 2014-11-27 US disclosed
US-8828923-B2 Insulin derivatives NOVO NORDISK A/S (DK) 2014-09-09 US disclosed
EP-2275439-B1 Novel insulin derivatives NOVO NORDISK AS (DK) 2014-03-26 EP disclosed
EP-2107069-B1 Novel insulin derivatives NOVO NORDISK AS (DK) 2013-01-16 EP disclosed
EP-2287184-A2 Novel insulin derivatives NOVO NORDISK A/S (DK) 2011-02-23 EP disclosed
EP-2275439-A2 Novel insulin derivatives NOVO NORDISK A/S (DK) 2011-01-19 EP disclosed
EP-2264065-A2 Novel Insulin Derivatives NOVO NORDISK A/S (DK) 2010-12-22 EP disclosed
EP-2264066-A2 Novel insulin derivatives NOVO NORDISK A/S (DK) 2010-12-22 EP disclosed
US-20100009899-A1 Novel Insulin Derivatives NOVO NORDISK A/S (DK) 2010-01-14 US disclosed
US-7615532-B2 Antidiabetic agents; insulin derivatives which are naturally occurring insulins or analogues thereof which have a side chain attached either to the alpha-amino group of the N-terminal amino acid residue of the B chain or to epsilon-amino group of a Lys residue present in the B chain of parent insulin NOVO NORDISK A/S (DE) 2009-11-10 US disclosed
EP-2107069-A2 Novel insulin derivatives NOVO NORDISK A/S (DK) 2009-10-07 EP disclosed
US-20060183668-A1 Antidiabetic agents; insulin derivatives which are naturally occurring insulins or analogues thereof which have a side chain attached either to the alpha-amino group of the N-terminal amino acid residue of the B chain or to epsilon-amino group of a Lys residue present in the B chain of parent insulin NOVO NORDISK A/S (DK) 2006-08-17 US disclosed
EP-1660531-A2 NOVEL INSULIN DERIVATIVES NOVO NORDISK A/S (DK) 2006-05-31 EP disclosed
WO-2005012347-A2 NOVEL INSULIN DERIVATIVES NOVO NORDISK A/S (DK) 2005-02-10 WO disclosed